Cargando…
Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells
A fundamental limitation of T cell therapies in solid tumors is loss of inflammatory effector functions, such as cytokine production and proliferation. Here, we target a regulatory axis of T cell inflammatory responses, Regnase-1 and Roquin-1, to enhance antitumor responses in human T cells engineer...
Autores principales: | Mai, David, Johnson, Omar, Reff, Jordan, Fan, Ting-Jia, Scholler, John, Sheppard, Neil C., June, Carl H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041166/ https://www.ncbi.nlm.nih.gov/pubmed/36920923 http://dx.doi.org/10.1073/pnas.2218632120 |
Ejemplares similares
-
Regnase-1 and Roquin regulate inflammatory mRNAs
por: Mino, Takashi, et al.
Publicado: (2015) -
Dynamic Regulation of the Nexus Between Stress Granules, Roquin, and Regnase-1 Underlies the Molecular Pathogenesis of Warfare Vesicants
por: Srivastava, Ritesh Kumar, et al.
Publicado: (2022) -
The silencing of ets-4 mRNA relies on the functional cooperation between REGE-1/Regnase-1 and RLE-1/Roquin-1
por: Sobańska, Daria, et al.
Publicado: (2022) -
Unrestrained cleavage of Roquin-1 by MALT1 induces spontaneous T cell activation and the development of autoimmunity
por: Schmidt, Henrik, et al.
Publicado: (2023) -
Regnase-1 is essential for B cell homeostasis to prevent immunopathology
por: Bhat, Numana, et al.
Publicado: (2021)